$169.32
2.431.46%
Last update: Nov 10, 4:13 AM
Gilead Sciences Inc
GILDNASDAQ
Gilead Sciences rose 43.3% from $118.15 to $169.32, ahead of the S&P 500's +10.5%. Its worst day was Nov 5 (−4.0%), and its low came Nov 10 at $118.15.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $1.86 beat the $1.83 estimate on $7.9B revenue (est. $7.6B); FY revenue guidance of $29.6B–$30.0B against the $30.1B consensus.
+5.8%, the year's best day · S&P 500 0.0%
Story events cover the past 12 months · Times ET
EPS of $2.03 beat the $1.91 estimate on $7.0B revenue (est. $6.9B); FY revenue guidance of $30.0B–$30.4B against the $30.2B consensus.
−2.0% · S&P 500 +0.8%
Gilead Sciences shares rose 5.2%, while the S&P 500 fell 0.5%.
+5.2% · S&P 500 −0.5%
EPS of $-6.75 beat the $-7.14 estimate on $7.8B revenue (est. $7.4B); FY revenue guidance of $30.1B–$30.4B against the $30.5B consensus.
−2.6% · S&P 500 −0.2%
EPS of $2.55 beat the $2.18 estimate on $8.3B revenue (est. $7.8B); FY revenue guidance of $31.0B–$31.3B against the $30.8B consensus.
+3.1% · S&P 500 −1.8%
Where it ended: a close of $169.32 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 9, 2027 (EPS est. $1.16, revenue est. $8.3B).
As of the Nov 9, 2026 close
Replay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for GILD and SPY from Benzinga historical bars. Not investment advice.
